Global Oral Transmucosal Drugs Market
Global Oral Transmucosal Drugs Market to Surpass $35 Billion by 2034, Rapid Growth Predicted in Asia-Pacific Propelled by Developments in Healthcare Infrastructure
March 12, 2024 12:15 ET | Research and Markets
Dublin, March 12, 2024 (GLOBE NEWSWIRE) -- The "Global Oral Transmucosal Drugs Market by Product Type, Route of Administration, Indication, Distribution Channel, and By Region" report has been added...
22157.jpg
Orally Disintegrating Tablet Market Report: Expanded Analysis, Trends, and Forecasts to 2031
February 06, 2024 06:25 ET | Research and Markets
Dublin, Feb. 06, 2024 (GLOBE NEWSWIRE) -- The "Orally Disintegrating Tablet Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade,...
Update: Fuisz Pharma Announces Issuance of Oral Thin Film Pharmaceutical Patent (re-release)
March 05, 2018 10:30 ET | Fuisz Pharma LLC
Miami, FL, March 05, 2018 (GLOBE NEWSWIRE) -- Fuisz Pharma LLC announced today the issuance of a new patent, US  9,901,545  (the “’545 Patent”) concerning the manufacture of oral thin film...
Fuisz Pharma Announces Issuance of Oral Thin Film Pharmaceutical Patent
March 05, 2018 07:30 ET | Fuisz Pharma LLC
Miami, FL, March 05, 2018 (GLOBE NEWSWIRE) -- Fuisz Pharma LLC announced today the issuance of a new patent, US  9,901,545  (the “’545 Patent”) concerning the manufacture of oral thin film...
FUISZ Announces Filing of Patent Application Relating to New Manufacturing Methods and Compositions for Oral Soluble Films, Superior to Wet Casting Methodologies
April 17, 2017 07:30 ET | Fuisz Pharma LLC
Bethlehem, PA, April 17, 2017 (GLOBE NEWSWIRE) -- Fuisz today announced the filing of a patent application with the United States Patent & Trademark Office relating to new methods of...